Defiance Daily Target 2X Long AMPX ETF (AMPU)

A 2X leveraged ETF on a battery startup amplifies all the wild swings of an early-stage deep-tech company — winning big on the good days, losing twice as much on the bad ones, and quietly bleeding value in markets where the stock bounces around without going anywhere.

AMPU tracks Amprius Technologies, a developer of high-energy-density batteries for electric vehicles, energy storage, and other applications. Amprius went public through a merger with a special-purpose acquisition company (SPAC) in late 2022 and trades under the ticker AMPX. AMPU takes daily exposure to AMPX and doubles it through leverage — a 3 percent gain in AMPX translates to a 6 percent gain in AMPU; a 4 percent loss becomes 8 percent down. The fund is managed by Defiance ETFs and resets its leverage to exactly 2X at the close of each trading day.

Why Amprius is so volatile

Amprius is a battery technology company at the commercialization stage. The company has developed a silicon nanowire anode technology intended to increase energy density and fast-charging capability relative to conventional lithium-ion batteries. It supplies samples to automotive and energy-storage customers for testing and qualification. Revenue is minimal; the business is burning cash and waiting for customers to convert prototype orders into production orders.

That situation makes Amprius a classic binary stock. It trades on milestone announcements and sentiment about whether the technology will be adopted at scale. News that a major automaker has qualified Amprius cells for a new platform can trigger a 20 percent jump. Competitive news from a rival battery maker, or a design-in loss, can cause a crash. This volatility is extreme because the company has no stable earnings, no recurring contracts, and a long commercialization runway. Binary early-stage companies are exactly where 2X leveraged ETFs hurt the most.

Daily reset decay in action

AMPU resets its 2X leverage target every day. On days when AMPX trends steadily upward, that reset is not costly — the fund captures the leverage cleanly. But when AMPX is choppy — up 5 percent one day, down 4 percent the next — the math works against the holder.

Here is a concrete example: Suppose AMPX starts at $10, rises 5 percent to $10.50 on day one, then falls 5 percent to $9.975 on day two. The net round-trip return is -0.25 percent. For AMPU at 2X daily leverage, the same pattern plays out as: up 10 percent on day one (to $11), down 10 percent on day two (to $9.90). The net round-trip return is -1 percent. The leveraged fund underperforms the underlying by 0.75 percentage points on that simple round trip.

Now scale that over weeks and months. AMPX, as a volatile biotech-style stock, will spend long periods whipsawing up and down. Every time it does, AMPU loses an extra slice of value because of the reset mechanics. The decay accelerates when there is a gap at the open — a sharp overnight move that reverses partially during the day.

The opportunity cost

Beyond the decay risk, there is a real opportunity cost: the margin or swap financing costs that underlie the leverage. AMPU holds AMPX shares (or derivative instruments that replicate the exposure) and borrows or enters into derivative contracts to add the second X of leverage. That financing costs something — usually a small percentage daily, but it compounds. On a quiet day when AMPX gains 0.5 percent, the leverage might capture 1 percent before financing costs eat 0.08 percent, netting 0.92 percent. The costs are published in the fund’s expense ratio, but they are real drags on returns.

Sector and company risk

Amprius is also sector-exposed. It is a battery play, benefiting from the world’s transition to electric vehicles and grid storage. But battery technology is crowded. Tesla manufactures its own cells. Established battery makers like CATL, BYD, and Panasonic have immense scale. Newer entrants like QuantumScape, Solid Power, and others are chasing advanced chemistries. Amprius has a real technical edge in energy density, but the commercial path is uncertain and the timeline is long. A major contract win for Amprius would send AMPX sharply higher (and AMPU along with it). A design-in loss or a customer deciding to internalize battery development would tank the stock.

For AMPU holders, this is the other side of the decay story: the stock is volatile in part because the company’s fate is uncertain. That volatility, combined with 2X leverage and daily reset mechanics, is a bad combination for buy-and-hold investors.

Who might use AMPU

AMPU is designed for active traders or speculators with a short-term thesis on Amprius. A trader who believes the company is on the verge of a major customer announcement, or that the stock is oversold and due for a bounce, might hold AMPU for a few days or a few weeks to capture the move amplified by 2X. Holding it for months or longer is a losing proposition due to decay. And holding it through the wrong type of volatility — wild intraday swings that reverse overnight — is especially costly.

How to research AMPU

Start with Amprius’ quarterly SEC filings and investor presentations, which detail the technology, the customers testing the product, and the commercialization timeline. Company press releases on customer wins and partnerships move the stock. Industry reports on battery adoption trends and the competitive landscape provide context. Financial data providers offer AMPU’s historical returns and volatility, and comparing it to AMPX’s own returns (adjusted for 2X leverage) is the best test of decay — if AMPU is significantly underperforming 2X the return of AMPX, decay is at work.